Indian generic manufacturers will produce lenacapavir, a near 100% effective, six-month injectable HIV prevention drug, ...

Without clear timelines and accountability, Ireland risks falling short of its goal to end new HIV transmissions by 2030.

A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce infections significantly.

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.

The announcement comes at a troubling time for global health, particularly in the fight against HIV/AIDS, as US foreign aid ...

New partnership will join others to expand access to generic lenacapavir for millions more people at risk of HIV in high-burden countries—bringing the world closer to ending the epidemic - Kenya ...

GENEVA/NEW YORK, 27 September 2025 —UNAIDS has wrapped up UNGA80 week with a productive mix of high-level events, announcements and decisions. The week kicked off with a face-to-face meeting of the ...

The White House details its Gaza peace deal plan. No breakthrough after Trump’s meeting with Democrats to avert a government ...

AllAfrica is a voice of, by and about Africa - aggregating, producing and distributing 500 news and information items daily ...

UNAIDS has wrapped up UNGA80 week with a productive mix of high-level events, announcements and decisions. The week kicked off with a face-to-face ...

NEW YORK, USA - His Majesty King Mswati III has called for resolute rejection of coups and non-recognition of any governments ...